subscription updateIPO Subscription Updates Goldline Pharmaceutical IPO Subscription Status Day 3: Final Oversubscription at 840.74×
Goldline Pharmaceutical IPO closed with 840.74× oversubscription on Day 3, driven by massive NII and retail demand, signaling strong market interest ahead of listing.
